<- Go Home
Forbion European Acquisition Corp.
As of October 31, 2023, Forbion European Acquisition Corp. was acquired by enGene, Inc., in a reverse merger transaction. Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.
Market Cap
$343.1M
Volume
67.8K
Cash and Equivalents
$85.7K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$47.17
52 Week Low
$9.25
Dividend
N/A
Price / Book Value
-22.48
Price / Earnings
-106.34
Price / Tangible Book Value
-22.48
Enterprise Value
$347.1M
Enterprise Value / EBITDA
N/A
Operating Income
-$9.1M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$85.7K
Debt
$4.2M
Equity
-$15.3M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium